What is the clinical evidence from this study?

Study design: Review. Population: Ischemic heart disease. Intervention: Intravenous dipyridamole.

January 1, 1990Clinical Cardiology

Update on intravenous dipyridamole cardiac imaging in the assessment of ischemic heart disease

View Full Paper

Ask AI

Bookmark

Key result

Intravenous dipyridamole thallium scintigraphy is a useful technique to assess myocardial perfusion in ischemic heart disease, with an average sensitivity of 76% and specificity of 70%.

Why the study?

Does intravenous dipyridamole combined with cardiac imaging accurately assess ischemic heart disease in patients unable to exercise?

Population

Patients with documented or suspected coronary artery disease, particularly those unable to exercise.

Design

Review

Authors

MYMustafa Z YounisUniversiti Putra Malaysia BCBernard ChaitmanAmerican College of Cardiology

Discussion

Member takes

Implication

Dipyridamole-thallium imaging may aid CAD perfusion assessment; leaves open its added prognostic value in contemporary cohorts.

Structured PICO

Does intravenous dipyridamole combined with cardiac imaging accurately assess ischemic heart disease in patients unable to exercise?

Population

Patients with documented or suspected coronary artery disease, particularly those unable to exercise.

Intervention

Intravenous dipyridamole (0.14 mg/kg/min for 4 minutes) combined with thallium-201 scintigraphy or other imaging modalities (e.g., echocardiography).

Outcome

Detection of regional differences in myocardial perfusion (ischemic heart disease) and prognostic information.surrogate

Intravenous dipyridamole combined with thallium-201 is a safe and useful pharmacological stress testing modality for assessing myocardial perfusion and prognosis in patients unable to exercise.

Limitations

absence of standard physiologic data which are acquired during exercise testing
need to stop theophylline or its derivatives 48 hours prior to testing
relatively low yield of ischemic electrocardiographic changes
Absence of standard physiologic data acquired during exercise testing
Need to stop theophylline or its derivatives 48 hours prior to testing
Relatively low yield of ischemic electrocardiographic changes

Cite This Study

Younis et al. (1990) conducted a review in Ischemic heart disease. Intravenous dipyridamole was evaluated. Intravenous dipyridamole thallium scintigraphy is a useful technique to assess myocardial perfusion in ischemic heart disease, with an average sensitivity of 76% and specificity of 70%.

synapsesocial.com/papers/6a62dcc64f5ef41b946a7a37 https://doi.org/10.1002/clc.4960130103

View Full Paper

Ask AI

Bookmark

Update on intravenous dipyridamole cardiac imaging in the assessment of ischemic heart disease

Discussion

Member takes

Implication

Structured PICO

Limitations

Cite This Study

Update on intravenous dipyridamole cardiac imaging in the assessment of ischemic heart disease

Discussion

Member takes

Implication

Structured PICO

Limitations

Cite This Study

Also Consider

Also Consider